A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial) (Q21144654)

From Wikidata

Jump to navigation Jump to search

scientific article

A Randomised, Blinded, Placebo-Controlled Trial in Dementia Patients Continuing or Stopping Neuroleptics (The DART-AD Trial)

Language	Label	Description	Also known as
English	A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial)	scientific article	A Randomised, Blinded, Placebo-Controlled Trial in Dementia Patients Continuing or Stopping Neuroleptics (The DART-AD Trial)

Statements

scholarly article

0 references

A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial) (English)

0 references

0 references

0 references

0 references

placebo-controlled trial

1 reference

based on heuristic

inferred from title

object named as

Ly-Mee Yu

8

author given names

Ly-Mee

author last names

Yu

1 reference

PubMed publication ID

16 August 2022

object named as

Clive Ballard

1

author given names

Clive

author last names

Ballard

1 reference

PubMed publication ID

16 August 2022

author name string

Marisa Margallo Lana

2

author given names

Marisa Margallo

author last names

Lana

1 reference

PubMed publication ID

16 August 2022

Megan Theodoulou

3

author given names

Megan

author last names

Theodoulou

1 reference

PubMed publication ID

16 August 2022

Simon Douglas

4

author given names

Simon

author last names

Douglas

1 reference

PubMed publication ID

16 August 2022

Rupert McShane

5

author given names

Rupert

author last names

McShane

1 reference

PubMed publication ID

16 August 2022

Robin Jacoby

6

author given names

Robin

author last names

Jacoby

1 reference

PubMed publication ID

16 August 2022

Katja Kossakowski

7

author given names

Katja

author last names

Kossakowski

1 reference

PubMed publication ID

16 August 2022

Edmund Juszczak

9

author given names

Edmund

author last names

Juszczak

1 reference

PubMed publication ID

16 August 2022

language of work or name

0 references

publication date

1 April 2008

0 references

0 references

5

0 references

4

0 references

e76

0 references

Global prevalence of dementia: a Delphi consensus study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

19 March 2017

Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

19 March 2017

Atypical antipsychotics for aggression and psychosis in Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

19 March 2017

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

19 March 2017

Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

12 September 2017

Neuroleptic drugs in dementia: benefits and harm

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

12 September 2017

Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

12 September 2017

Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

12 September 2017

Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

12 September 2017

Haloperidol for agitation in dementia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

12 September 2017

The severe impairment battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

12 September 2017

Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

12 September 2017

A metaanalysis of controlled trials of neuroleptic treatment in dementia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

12 September 2017

Survey of neuroleptic prescribing in residents of nursing homes in Glasgow

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

27 September 2017

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

27 September 2017

The impact of the symptoms of dementia on caregivers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

27 September 2017

The sensitivity to change over time of the Bristol Activities of Daily Living Scale in Alzheimer's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

30 May 2018

Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

30 May 2018

Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

30 May 2018

Hallucinations and associated factors in Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

30 May 2018

Functional assessment staging (FAST) in Alzheimer's disease: reliability, validity, and ordinality.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

30 May 2018

Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

29 November 2018

Correlates of anticholinergic activity in patients with dementia and psychosis treated with risperidone or olanzapine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

29 November 2018

A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

29 November 2018

Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

29 November 2018

A 1-year follow-up study of behavioral and psychological symptoms in dementia among people in care environments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

29 November 2018

Withdrawal of haloperidol, thioridazine, and lorazepam in the nursing home: a controlled, double-blind study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

29 November 2018

The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

29 November 2018

Reliability of a Standardized Mini-Mental State Examination compared with the traditional Mini-Mental State Examination.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276521

29 November 2018

The impact of dementia on the family

1 reference

https://pubmed.ncbi.nlm.nih.gov/18384230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Withdrawal of Neuroleptic Medications from Institutionalized Dementia Patients: Results of a Double-Blind, Baseline-Treatment—Controlled Pilot Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18384230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18384230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments

1 reference

https://pubmed.ncbi.nlm.nih.gov/18384230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for the management of agitation in dementia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18384230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PMED.0050076

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

release_5fy5uohdejhmpjbbahhm72gsbm

1 reference

https://api.fatcat.wiki/v0/release/5fy5uohdejhmpjbbahhm72gsbm

24 November 2022

based on heuristic

mapped directly with Wikidata item

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q21144654&oldid=1838002524"